New Key Statistics Module, Z-Score and F-Score
NAS:BRNS Key Ratios
| Market Cap $ M | 38.41 |
| Enterprise Value $ M | -55.02 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.24 |
| Price/Sales | 2.51 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 14.00 |
| EPS (TTM) $ | -1.49 |
| Beneish M-Score | -1.06 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.94 |
| EV-to-EBITDA | 1.04 |
| PEG | -- |
| Shares Outstanding M | 40.23 |
| Net Margin (%) | -386.31 |
| Operating Margin % | -415.08 |
| Pre-tax Margin (%) | -392.47 |
| Quick Ratio | 8.93 |
| Current Ratio | 8.93 |
| ROA % (ttm) | -28.36 |
| ROE % (ttm) | -33.24 |
| ROIC % (ttm) | -95.94 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.01 |
BRNS Number of Guru Trades
BRNS Volume of Guru Trades
Gurus Latest Trades with NAS:BRNS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:BRNS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Barinthus Biotherapeutics PLC Insider Transactions
No Available Data
News about NAS:BRNS
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers